 open label study oral transmucosal fentanyl citrate OTFC treatment breakthrough cancer pain patients advanced cancer breakthrough pain ages oral transmucosal fentanyl citrate micrograms/kg times days total administrations open study Baseline vital sign rating scale results vary administrations heart rate beats/min decrease administrations Heart rate oxygen saturation vary min evaluation minimal changes blood pressure respiration rate Significant reduction pain scores pain descriptive scale McGill-Melzack scale numeric VAS scale evaluations min Average time pain relief min administration Wellbeing evaluations Activity level investigator min administration activity level patient min min OTFC administration significant adverse effects